TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | -2 | 2 | 1 | 7 | -4 | -47 | -7 |
| P | %wins | 0 | 100 | 100 | 100 | 0 | 0 | 50 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/27/07 16:34 | 6/26/07 | LXRX | Lexicon Pharmaceuticals, Inc./de | DE | Health | Drug | Pharmaceutical Preparations | Rose Clayton Stuart | TX | D | P | 48 | 3.19 | 0 | 15 | 150 | 25 | D | -31 | -26 | -15 | -15 | -6 | 4 | 4 | -5 | -2 | 2 | 1 | 7 | -4 | -47 | |
8/5/04 17:08 | 8/4/04 | LEXG | Lexicon Genetics Inc/tx | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Rose Clayton Stuart | TX | D | P | 59 | 5.85 | 0 | 10 | New | 10 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |